Total Payments
$24,254
2024 Payments
$2,440
Companies
51
Transactions
999
Medicare Patients
695
Medicare Billing
$76,986
Payment Breakdown by Category
Food & Beverage$15,911 (65.6%)
Consulting$5,950 (24.5%)
Travel$2,393 (9.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,911 | 989 | 65.6% |
| Consulting Fee | $5,950 | 2 | 24.5% |
| Travel and Lodging | $2,393 | 8 | 9.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $12,392 | 189 | $0 (2024) |
| ViiV Healthcare Company | $2,387 | 141 | $0 (2024) |
| ABBVIE INC. | $1,115 | 73 | $0 (2024) |
| Novo Nordisk Inc | $952.22 | 99 | $0 (2024) |
| Merck Sharp & Dohme LLC | $948.90 | 91 | $0 (2024) |
| GlaxoSmithKline, LLC. | $846.46 | 48 | $0 (2024) |
| Lilly USA, LLC | $644.63 | 44 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $609.75 | 46 | $0 (2024) |
| Amgen Inc. | $482.64 | 28 | $0 (2024) |
| Janssen Biotech, Inc. | $418.75 | 28 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,440 | 109 | ViiV Healthcare Company ($728.95) |
| 2023 | $2,816 | 155 | ViiV Healthcare Company ($513.84) |
| 2022 | $2,035 | 111 | Gilead Sciences, Inc. ($424.53) |
| 2021 | $371.92 | 22 | AbbVie Inc. ($132.24) |
| 2020 | $533.22 | 34 | Gilead Sciences, Inc. ($85.97) |
| 2019 | $6,933 | 192 | Gilead Sciences, Inc. ($5,190) |
| 2018 | $2,579 | 192 | Gilead Sciences, Inc. ($811.96) |
| 2017 | $6,546 | 184 | Gilead Sciences Inc ($4,732) |
All Payment Transactions
999 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: HIV | ||||||
| 12/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $90.09 | General |
| 12/10/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: VACCINE | ||||||
| 12/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.51 | General |
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.80 | General |
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: HIV | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: HIV | ||||||
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes Care | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.33 | General |
| 11/01/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: HIV | ||||||
| 10/31/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: HIV | ||||||
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.37 | General |
| 10/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Oncology | ||||||
| 10/17/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: HIV | ||||||
| 10/16/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: HIV | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 159 | 214 | $33,393 | $19,147 |
| 2022 | 6 | 172 | 224 | $34,039 | $20,314 |
| 2021 | 7 | 179 | 240 | $32,984 | $20,436 |
| 2020 | 7 | 185 | 252 | $33,690 | $17,089 |
Total Patients
695
Total Services
930
Medicare Billing
$76,986
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 113 | $23,278 | $12,859 | 55.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 27 | 27 | $4,050 | $3,499 | 86.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 34 | $4,760 | $2,158 | 45.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 21 | 21 | $735.00 | $416.10 | 56.6% |
| 90471 | Administration of vaccine | Office | 2023 | 18 | 19 | $570.00 | $213.85 | 37.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 67 | 114 | $23,484 | $13,294 | 56.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $4,950 | $4,237 | 85.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 29 | $4,060 | $1,847 | 45.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 21 | 21 | $735.00 | $421.80 | 57.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $330.00 | $323.40 | 98.0% |
| 90471 | Administration of vaccine | Office | 2022 | 16 | 16 | $480.00 | $191.38 | 39.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 58 | 104 | $21,424 | $12,023 | 56.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 32 | 32 | $4,800 | $4,327 | 90.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 32 | $4,480 | $2,890 | 64.5% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 24 | 24 | $840.00 | $624.14 | 74.3% |
| 99421 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes | Office | 2021 | 19 | 24 | $720.00 | $220.50 | 30.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $390.00 | $210.84 | 54.1% |
| 90471 | Administration of 1 vaccine | Office | 2021 | 11 | 11 | $330.00 | $140.60 | 42.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 51 | 90 | $18,540 | $8,418 | 45.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 34 | 56 | $7,840 | $3,782 | 48.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 27 | 27 | $4,050 | $3,180 | 78.5% |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 20 | 20 | $650.00 | $584.60 | 89.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 14 | $1,260 | $489.00 | 38.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 21 | 22 | $660.00 | $375.20 | 56.8% |
| 99421 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes | Office | 2020 | 20 | 23 | $690.00 | $260.19 | 37.7% |
About Dr. Gary Werntz, M.D
Dr. Gary Werntz, M.D is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952301285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Werntz, M.D has received a total of $24,254 in payments from pharmaceutical and medical device companies, with $2,440 received in 2024. These payments were reported across 999 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($15,911).
As a Medicare-enrolled provider, Werntz has provided services to 695 Medicare beneficiaries, totaling 930 services with total Medicare billing of $76,986. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 07/28/2005
- Last Updated 03/07/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1952301285
Products in Payments
- Descovy (Drug) $4,542
- APRETUDE (Biological) $593.53
- VRAYLAR (Drug) $544.47
- DOVATO (Drug) $524.32
- TRELEGY ELLIPTA (Drug) $491.02
- Trintellix (Drug) $456.26
- ISENTRESS (Drug) $390.05
- RUKOBIA (Drug) $385.01
- MOUNJARO (Drug) $296.08
- CABENUVA (Biological) $293.92
- JANUVIA (Drug) $288.60
- JULUCA (Drug) $286.76
- TRIUMEQ (Drug) $282.53
- Repatha (Biological) $267.22
- Ozempic (Drug) $251.96
- Biktarvy (Drug) $249.40
- Rybelsus (Drug) $231.74
- XIFAXAN (Drug) $231.31
- NURTEC ODT (Drug) $221.23
- JARDIANCE (Drug) $219.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Family Medicine $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
Family Medicine $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Family Medicine $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Family Medicine $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Family Medicine $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768
Family Medicine $32,768